BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31828418)

  • 1. Immunohistochemical expression of TFIIH and XPF in oral tongue squamous cell carcinoma.
    Sá MC; Conceição TS; de Moura Santos E; de Morais EF; Galvão HC; de Almeida Freitas R
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):893-902. PubMed ID: 31828418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic grading and its relationship with outcome in oral tongue squamous cell carcinoma.
    Silva LABD; Lopes MLDS; Sá MC; de Almeida Freitas R; Coletta RD; da Silveira EJD; da Costa Miguel MC
    J Oral Pathol Med; 2021 Feb; 50(2):183-190. PubMed ID: 33151566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
    Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
    J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of DNA repair proteins in oral tongue and lower lip squamous cell carcinoma.
    Moreira DGL; Morais EF; Santos HBP; Freitas RA
    Braz Oral Res; 2020 Sep; 34():e101. PubMed ID: 32901726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern and localization of perineural invasion predict poor survival in oral tongue carcinoma.
    Caponio VCA; Troiano G; Togni L; Zhurakivska K; Santarelli A; Laino L; Rubini C; Lo Muzio L; Mascitti M
    Oral Dis; 2023 Mar; 29(2):411-422. PubMed ID: 33964054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
    Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
    J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tumor budding thresholds in oral tongue squamous cell carcinoma.
    Mascitti M; Togni L; Caponio VCA; Zhurakivska K; Lo Muzio L; Rubini C; Santarelli A; Troiano G
    Oral Dis; 2023 Jul; 29(5):1947-1958. PubMed ID: 35316866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
    Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
    Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma.
    Dong Y; Chen X; Li H; Ni Y; Han W; Wang J
    Pol J Pathol; 2017; 68(1):49-54. PubMed ID: 28547980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI correlates to histopathological data in oral tongue squamous cell carcinoma diagnostics.
    Huopainen P; Jouhi L; Hagstrom J; Apajalahti S
    Acta Odontol Scand; 2021 Apr; 79(3):161-166. PubMed ID: 32654567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological prognosticators and their clinicopathological correlation in oral squamous cell carcinomas of the tongue.
    Pallavi K; Tandon A; Gulati N; Juneja S; Shetty DC
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S226-S232. PubMed ID: 36510969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma.
    Santana T; Sá MC; de Moura Santos E; Galvão HC; Coletta RD; Freitas RA
    J Oral Pathol Med; 2017 Aug; 46(7):496-503. PubMed ID: 27925687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
    Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
    Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report.
    Bjerkli IH; Laurvik H; Nginamau ES; Søland TM; Costea D; Hov H; Uhlin-Hansen L; Hadler-Olsen E; Steigen SE
    PLoS One; 2020; 15(9):e0239783. PubMed ID: 32976535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years.
    Faisal M; Dhanani R; Ullah S; Bakar MA; Irfan N; Malik KI; Loya A; Boban EM; Hussain R; Jamshed A
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3045-3053. PubMed ID: 33236214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological correlation of P
    Ravishankar B; Madhavi BV; Kalagara A; Bodepudi S; Harnadh S; Bindu PJ; Pydi VR; Raj BP; Nitya G; Rishik B
    Pathol Res Pract; 2024 Jan; 253():155071. PubMed ID: 38181580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
    Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
    J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Expression Helps Identify High Risk Oral Tongue Pre- malignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases.
    Viveka TS; Shyamsundar V; Krishnamurthy A; Ramani P; Ramshankar V
    Asian Pac J Cancer Prev; 2016; 17(1):189-95. PubMed ID: 26838208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
    Liu L; Wang X; Ge W
    Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.